Insider filing · NTRA
Roy D. Baynes
Director
profile →
Natera, Inc.
NTRA · Healthcare · 229 filings in 24 months
ticker →
Roy D. Baynes sold $2.8M of Natera (NTRA)
Executed Nov 19 2025, disclosed Nov 21 2025, 2 days later.
Value, as filed
$2.8M
12,780 sh across 8 lots
Executed
Nov 19 2025
the trade date, as filed
Disclosed
Nov 21 2025
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
RBRoy D. Baynes (Director) filed 6 Form 4 reports in the trailing twelve months (0 purchases, 6 sales), most often in Travere Therapeutics, Inc. (TVTX). The largest single filing was $2.8M of NTRA (12,780 sh across 8 lots, as filed), executed Nov 19 2025.
The name
NTRAHealthcare · Natera, Inc., a diagnostics company, engages in the development and commercialization of molecular testing services worldwide
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Roy D. Baynes in NTRA
NTRASALE
Natera, Inc.
$5.4M37,230 sh across 6 lots
Exec Nov 15 2024
Filed Nov 15 2024 · 5:30 PM ET